Gaisser, S.S.GaisserHopkins, M.M.M.M.HopkinsLiddell, K.K.LiddellZika, E.E.ZikaIbarreta, D.D.Ibarreta2022-03-042022-03-042009https://publica.fraunhofer.de/handle/publica/21843910.1038/458407a2-s2.0-63649098906In this, the second of two Commentaries, Sibylle Gaisser, Michael M. Hopkins and colleagues discuss a survey demonstrating that European health-care systems are ill prepared for the commercial reality of gene patents.en303500journal article